Clinical Trials Logo

Clinical Trial Summary

To find the overall psychological profile of patients with Behcet's Disease (BD) and compare it with Non-BD patients.patients were checked for psychological symptoms by Symptom Check List 90 Revised (SCL90-R)


Clinical Trial Description

200 BD and 200 Non-BD patients were checked for psychological symptoms by Symptom Check List 90 Revised (SCL90-R). BD diagnosis was based on the new International Criteria for Behcet's Disease (ICBD). Non-BD patients were patients mimicking BD. All patients were asked to complete the SCL90-R when they attended the clinic for their routine follow-up. The demographic information and disease manifestations including ocular and neurological involvement were registered. For those with visual impairment, SCL90-R was applied by an interviewer. Frequencies and descriptive analysis were measured in both BD and Non-BD groups. Means and standard deviations (SD) of visual acuity were calculated. Data collected from SCL90-R did not have normal distribution in any dimension. The mean values of raw numbers, global severity index (GSI), the positive symptoms total (PST) and the positive symptom distress index (PSDI), were compared by Mann-Whitney U (M-W U) test.).To detect any bias in results due to data collection method, self reported data and reviewer collected data were compared. ;


Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT00699985
Study type Observational
Source Tehran University of Medical Sciences
Contact
Status Completed
Phase N/A
Start date September 2006
Completion date December 2007

See also
  Status Clinical Trial Phase
Completed NCT00001865 - HAT in Eye Complications of Behcet's Disease Phase 2
Terminated NCT00550498 - Stem Cell Transplantation in Ocular Lesions of Behcet's Disease Phase 1
Completed NCT00700297 - Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease Phase 2
Completed NCT00664599 - Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease Phase 2